Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 24,000 shares at $52.48 ($1.3M) on 2020-10-14, disclosed to the SEC on 2020-10-16.
Open-market sale of $1.3M ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.48 | 4,649 | $244K | 19.2% |
| 2 | $52.48 | 4,649 | $244K | 19.2% |
| 3 | $53.07 | 7,351 | $390K | 30.8% |
| 4 | $53.07 | 7,351 | $390K | 30.8% |
| Total | $52.84 avg | 24,000 | $1.3M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |